Covered recipient · General Payments record
ANGELA M STOLLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$3,551.21
- Reported across 193 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.00 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $69.81 | 4 |
| ABBVIE INC. | $51.19 | 3 |
| PFIZER INC. | $49.87 | 3 |
| Novo Nordisk AS | $36.26 | 2 |
| Lilly USA, LLC | $31.50 | 2 |
| Exact Sciences Corporation | $19.33 | 1 |
| DEXCOM, INC. | $18.04 | 1 |
| Antares Pharma, Inc. | $16.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.54 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203628762 | CMS |
| ABBVIE INC. | $17.45 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203628768 | CMS |
| ABBVIE INC. | $20.20 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203628774 | CMS |
| Antares Pharma, Inc. | $16.00 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235915201 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.47 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206475719 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.04 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206626566 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.98 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206248946 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.32 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206567330 | CMS |
| Dexcom, Inc. | $18.04 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250543418 | CMS |
| Exact Sciences Corporation | $19.33 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235236236 | CMS |
| Lilly USA, LLC | $14.02 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186953823 | CMS |
| Lilly USA, LLC | $17.48 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187065706 | CMS |
| Novo Nordisk Inc | $17.32 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188344975 | CMS |
| Novo Nordisk Inc | $18.94 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188411092 | CMS |
| PFIZER INC. | $17.02 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228899412 | CMS |
| PFIZER INC. | $14.74 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229867157 | CMS |
| PFIZER INC. | $18.11 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230738472 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.